Describe mediante indicadores bibliométricos la producción científica en Scopus sobre la capacidad diagnostica del bilirrubinómetro transcutáneo en recién nacidos. La ictericia neonatal es una de las afecciones más frecuentes en recién nacidos a término y pretérmino, donde el nivel elevado de bilirrubina puede repercutir en el sistema nervioso e incluso provocar la muerte del recién nacido. Debido a la necesidad de lograr un manejo temprano, fue creado el bilirrubinómetro transcutáneo para estimar de forma no invasiva los niveles de bilirrubina en el recién nacido. Sin embargo, es necesario conocer la distribución y evolución de su producción científica a nivel mundial. Fue realizado un análisis bibliométrico a partir de la búsqueda avanzada en la base de datos Scopus. Se recopilaron datos bibliométricos, que fueron analizados con los softwares Bibliometrix, VOSview...

Noncommunicable diseases (NCDs) are a major cause of disease burden in Peru as well as in other developing countries. Responses to control NCDs require multidisciplinary research, both locally and internationally. The CRONICAS Center of Excellence in Chronic Diseases at Universidad Peruana Cayetano Heredia, in Peru, has conducted scientific research in the field of NCDs in Peru for more than 10 years. This article highlights some of the scientific research, including epidemiological studies such as the PERU MIGRANT study, and the CRONICAS cohort study. We also summarize our results from systematic reviews in the field of NCDs and results of interventions to tackle NCDs. The scientific research studies conducted by CRONICAS signal potential advancements to counter NCDs in developing countries.

Background & Aims: Vasoactive agents with endoscopic therapy are used to treat acute variceal bleeding (AVB). There are two main groups of vasoactive agents: terlipressin and vasopressin (T-V), and octreotide and somatostatin (O-S). However, the benefit/harm balance is unclear. Our aim was to assess the efficacy and safety of T-V versus O-S for the management of AVB. Methods: We performed a systematic search for randomized controlled trials (RCTs) in PubMed, Scopus, and CENTRAL. Our main outcomes were mortality and adverse events. Secondary outcomes were bleeding control, rebleeding, blood transfusion, hospital stay. We evaluated the certainty of evidence using GRADE methodology. Results: We included 21 RCTs. The risk of mortality (RR: 1.01; 95%CI: 0.83-1.22), bleeding control (RR: 0.96; 95%CI: 0.91-1.02; I2=53%), early rebleeding (RR: 0.91; 95%CI: 0.66-1.24: I2=0%), late rebleeding (RR:...